Lipids and Obesity

Main Reference

Temporal Shifts in Oral Environment of Patients with Metabolic Syndrome and Obesity following Intervention

Endocrinology Lipids and Obesity Pediatric Subjects Adult Subjects Female Subjects Male Subjects

INVESTIGATION OF THE EFFECT OF ANTIOXIDANT THERAPY AND SIRT1 STIMULATION IN PATIENTS WITH NON ALCHOLIC FATTY LIVER DISEASE FROM METABOLIC SYNDROME

Internal Medicine Gastroenterology Endocrinology Liver Disease Lipids and Obesity Adult Subjects Female Subjects Male Subjects

Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies (BROOKLYN): A Placebo-Controlled, Double-Blind, Randomized, Phase 3 Study to Evaluate the Effect of 10 mg Obicetrapib in Participants With a History of HeFH and LDL-C >/=70 mg/dL Who ar…

Internal Medicine Endocrinology Lipids and Obesity Adult Subjects

This study will be a placebo-controlled, double-blind, randomized, phase 3 study to Evaluate the Efficacy, Safety, and Tolerability of Obicetrapib in Participants with a History of Heterozygous Familial Hypercholesterolemia (HeFH).

Metabolic Syndrome (MetS) and Perturbations in the Subgingival Ecosystem

Endocrinology Lipids and Obesity Pediatric Subjects Adult Subjects Female Subjects Male Subjects

Subscribe to Lipids and Obesity

Attention Site Visitor

Temporal Shifts in Oral Environment of Patients with Metabolic Syndrome and Obesity following Intervention

INVESTIGATION OF THE EFFECT OF ANTIOXIDANT THERAPY AND SIRT1 STIMULATION IN PATIENTS WITH NON ALCHOLIC FATTY LIVER DISEASE FROM METABOLIC SYNDROME

Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies (BROOKLYN): A Placebo-Controlled, Double-Blind, Randomized, Phase 3 Study to Evaluate the Effect of 10 mg Obicetrapib in Participants With a History of HeFH and LDL-C >/=70 mg/dL Who ar…

Metabolic Syndrome (MetS) and Perturbations in the Subgingival Ecosystem